SELLAS Life Sciences (SLS) announced that clinical data from its ongoing Phase 2 study of SLS009, a highly selective CDK9 inhibitor, in ...

The average one-year price target for SELLAS Life Sciences Group (NASDAQ:SLS) has been revised to 7.14 / share. This is an increase of 16.67% from the prior estimate of 6.12 dated October 31, 2023.

SLS Hotels & Residences has unveiled its first all-inclusive property, the SLS Playa Mujeres, located just 15 miles north of Cancun International Airport. Situated in a gated beachfront community, the ...

SELLAS Life Sciences Gr (SLS) is scheduled to report earnings on November 12, 2025. The last reported earnings were for reported on August 12, 2025 for Q2.

We came across a bullish thesis on Sellas Life Sciences Group Inc (SLS) on ValueInvestorsClub by ContraMundem. In this article we will summarize the bulls’ thesis on SLS. Sellas Life Sciences shares ...

SELLAS Life Sciences Group Inc. SLS shares rallied Tuesday as retail traders try to push the stock higher. The stock is likely continuing its momentum after the company secured a U.S. patent for ...

NEW YORK, Nov. 30, 2023 /PRNewswire/ -- SOCOTEC USA, a leading provider of TIC (Testing, Inspection, and Certification), consulting, and advisory services with a strategic focus on buildings and ...

PALO ALTO, Calif., September 23, 2025--(BUSINESS WIRE)--MEDiC Life Sciences, a leader in next-generation functional genomics in 3D cancer models, today announced the acquisition of a clinical-stage ...